CompoAtlas

Joint Support

Joint Support, licence 80076148: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Nutramagic Inc.
NPN or DIN-HM
80076148
Status
Inactive licence
Licence date
16 March 2017
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Méthylsulfonylméthane

Source : Synthétique

10.0 milligrammeNot calculated
Sulfate de 2-amino-2-désoxy-D-glucose

Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes

375.0 milligrammeNot calculated
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 40:1

Dry plant equivalent : 400 milligramme

10.0 milligrammeNot calculated
Sulfate de chondroïtine

Source : Chondroitin sulfate sodium obtained from avian cartilage

30.0 milligrammeNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : bactéries, levures

15.0 milligrammeNot calculated
Ginkgo biloba L.

Source : Feuille

Extraction ratio : 50:1

Dry plant equivalent : 1.5 Grammes

Potency : 24.0 % flavone glycosides

30.0 milligrammeNot calculated
Ginkgo biloba L.

Source : Feuille

Potency : 6.0 % terpene lactones

Not specifiedNot calculated
3,3',4',5,7-Pentahydroxyflavone

Source : Vaccinium myrtillus - Fruit

150.0 milligrammeNot calculated
Vitamine C

Source : Acide ascorbique

20.0 milligramme80,000 µg
Vitis vinifera L.

Source : Graine(s)

Potency : 85.0 % Oligomeric proanthocyanidins

20.0 milligrammeNot calculated

Non-medicinal ingredients

chlorophylle, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associate with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. Source of antioxidants for the maintenance of good health. Helps in the development and maintenance of bones. Helps in the development and maintenance of cartilage. Helps in connective tissue formation. Helps in wound healing.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80076148

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line